Literature DB >> 2281043

The development of USP dissolution and drug release standards.

J L Cohen1, B B Hubert, L J Leeson, C T Rhodes, J R Robinson, T J Roseman, E Shefter.   

Abstract

Dissolution tests have been in use in the pharmaceutical industry for over 20 years, and they are official in The United States Pharmacopeia since the early 1960s. The dissolution test, reviewed primarily as a quality control tool, replaced the use of disintegration tests which had been official in The United States Pharmacopeia since 1950. Refinements in the dissolution test equipment and methodology have occurred over the years in order to enhance its relevance. The Subcommittees of the USP Committee of Revision dealing with these issues have developed and refined compendial dissolution standards and policies for conventional solid-oral dosage forms and modified-release dosage forms.

Mesh:

Substances:

Year:  1990        PMID: 2281043     DOI: 10.1023/a:1015922629207

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  11 in total

1.  Formulation of a novel tianeptine sodium orodispersible film.

Authors:  Doaa Ahmed El-Setouhy; Nevine Shawky Abd El-Malak; Nevine Shawky Abd El-Malak
Journal:  AAPS PharmSciTech       Date:  2010-06-08       Impact factor: 3.246

2.  Velocity distribution and shear rate variability resulting from changes in the impeller location in the USP dissolution testing apparatus II.

Authors:  Ge Bai; Piero M Armenante
Journal:  Pharm Res       Date:  2007-11-27       Impact factor: 4.200

Review 3.  The science of USP 1 and 2 dissolution: present challenges and future relevance.

Authors:  Vivian Gray; Gregg Kelly; Min Xia; Chris Butler; Saji Thomas; Stephen Mayock
Journal:  Pharm Res       Date:  2009-01-23       Impact factor: 4.200

4.  Transfer of drug dissolution testing by statistical approaches: Case study.

Authors:  Mohammed Amood Al-Kamarany; Miloud El Karbane; Khadija Ridouan; Fars K Alanazi; Philippe Hubert; Yahia Cherrah; Abdelaziz Bouklouze
Journal:  Saudi Pharm J       Date:  2011-09-16       Impact factor: 4.330

5.  In vitro dissolution testing with flow-through method: a technical note.

Authors:  Zongming Gao
Journal:  AAPS PharmSciTech       Date:  2009-11-24       Impact factor: 3.246

6.  Characterization of fluids from the stomach and proximal jejunum in men and women.

Authors:  A Lindahl; A L Ungell; L Knutson; H Lennernäs
Journal:  Pharm Res       Date:  1997-04       Impact factor: 4.200

7.  The influence of the compression force on zidovudine release from matrix tablets.

Authors:  Jucimary V Santos; Luís A E Batista de Carvalho; Maria Eugénia Tavares Pina
Journal:  AAPS PharmSciTech       Date:  2010-09-15       Impact factor: 3.246

8.  Design and in vitro evaluation of novel sustained-release double-layer tablets of lornoxicam: utility of cyclodextrin and xanthan gum combination.

Authors:  Yassin El-Said Hamza; Mona Hassan Aburahma
Journal:  AAPS PharmSciTech       Date:  2009-11-18       Impact factor: 3.246

9.  Preparation and in-vivo pharmacokinetic study of a novel extended release compression coated tablets of fenoterol hydrobromide.

Authors:  Ahmed H Elshafeey; Elshaimaa I Sami
Journal:  AAPS PharmSciTech       Date:  2008-09-03       Impact factor: 3.246

10.  Ultrahigh verapamil-loaded controlled release polymeric beads using superamphiphobic substrate: D-optimal statistical design, in vitro and in vivo performance.

Authors:  Carol Yousry; Maha M Amin; Ahmed H Elshafeey; Omaima N El Gazayerly
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.